Global ETF Survey 2026: Answer now →
Help us improve your experience. Please confirm your investor type:
The ETF Industry Is Evolving Fast
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.
PJP ETF · Invesco Dynamic Pharmaceuticals ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +6.64%  | +11.01%  | +39.89% | +55.84% | +47.29% | +3.72% | +9.59% | +9.21% | |
| Flows |
Key fund info
Essentials
Enterprise
Similar ETFs in your region
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +11.01% | +39.89% | +55.84% | +47.29% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about PJP ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
PJP’s has a Final Sustainability Grade of either A+, A, or A-.
Replication
Issuer
| AuM | ||
|---|---|---|
QQQ | Invesco QQQ ETF | €416.54B |
QQQM | Invesco NASDAQ 100 ETF | €84.04B |
RSP | Invesco S&P 500® Equal Weight ETF | €79.85B |
SPXS | Invesco S&P 500 UCITS ETF | €34.22B |
SGLD | Invesco Physical Gold ETC | €22.65B |
Frequently asked questions about PJP
What does Invesco Dynamic Pharmaceuticals ETF, PJP, invest in?
PJP is a Passive ETF. This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities.
Which benchmark or index does PJP replicate?
PJP tracks the Dynamic Pharmaceutical Intellidex Total Return Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of PJP?
PJP carries a total expense ratio (TER) of 0.57%, indicating the annual cost for holding the fund.
When was PJP launched?
PJP was introduced to the market on June 23, 2005. It trades on United States
Who is the ETF issuer of PJP?
Invesco Dynamic Pharmaceuticals ETF, PJP, is provided by Invesco. Learn more about Invesco here.
What is the current assets under management (AUM) of PJP?
PJP oversees €303M in assets as of June 12, 2026.
How has PJP performed lately?
Based on data from June 12, 2026, PJP returned 6.64% over the past month, 11.01% over the last three months and 9.21% year-to-date.
What are the latest inflows or outflows for PJP?
As of June 12, 2026, PJP recorded net flows of -€3.8M over the last month and +€6.7M year-to-date.
Does PJP distribute dividends?
PJP follows a distributing dividend policy, meaning it pays out income to investors. As of June 12, 2026, its 12-month trailing yield was 0.93%.
What are the main country or region exposures of PJP?
As of April 30, 2026, PJP has significant geographic allocations in USA and Ireland.
In which sector or theme does PJP invest in?
As of April 30, 2026, PJP focuses largely on Health Care.
How many securities does PJP hold and how diversified is it?
As of April 30, 2026, PJP holds 29 positions in its portfolio, with 62.71% of assets concentrated in its top 15 holdings.
What are the main positions in PJP?
As of April 30, 2026, PJP top three holdings include PFIZER, JOHNSON&JOHNSON and MERCK & CO INC.
What is the base currency of PJP?
The base currency of PJP is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
